Curedmincis A Biopharmaceutical Company Established To Develop New Therapies That May Preventameliorateor Reversediabetes And Allow For Thediscontinuation Of Insulin Theresearch Team At Curedm Has Discovered And Is Developing A Novel Human Peptideassociated With Regeneration Of Insulin Producing Islets Within Thepancreasthis Peptidecalled Human Proislet Peptidehip Also Known Aspancreatea C Stimulates Thedifferentiation Of New Insulin Producing Islets From Existing Adult Pancreatic Progenitor Cellsrestoration Of Pancreatic Function May Beachievedwithout Theuseof Stem Cells By Clinical Treatment With This Peptidetherapeuticthecuredm Approach Is To Restoremaintain And Protect New Insulin Producing Islet Structures In Patients With Diabetes Products Will Belicensed Out Or Partnered To Pharmaceutical Companies Who Havean Established Commercial Track Record And Presencefor Distributionsales And Marketing In All Or Selected Geographic Or Therapeutic Areas
